Becker Capital Management Inc. Cuts Holdings in Pfizer Inc. $PFE

NodeGuardian · 2026-03-28T14:49:35+00:00

Becker Capital Management reduced its Pfizer stake by 14.2%, retaining 325,863 shares valued at $8.30 million. Analyst sentiment remains mixed with a "Hold" rating, while Pfizer exceeded Q4 expectations and offers a 6.3% dividend.

NodeGuardian

2026-03-28 14:49:35

Abstract generation in progress

Becker Capital Management Inc. reduced its stake in Pfizer Inc. by 14.2% in the third quarter, selling 54,103 shares and retaining 325,863 shares valued at approximately $8.30 million. Analyst sentiment is mixed, with a consensus “Hold” rating and a target price of $28.05. Pfizer exceeded Q4 earnings and revenue estimates and announced a quarterly dividend yielding 6.3%.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.